Biosense Webster Carto 3 Multi-Electrode Mapping System Provides Speed, Greater Accuracy

New system provides a fast mapping, diagnoses of arrhythmias using sensor-based MEM-enabled catheters to maintain a high anatomical accuracy


August 14, 2012

The Biosense Webster Carto 3 MEM (Multi-Electrode Mapping) version was launched in the United States in August 2012. It is the latest advancement on the Carto 3 system platform.

Based on market-leading electromagnetic technology, the new Carto 3 MEM version provides a fast method for mapping and diagnosing arrhythmias, while using sensor-based MEM-enabled catheters to maintain a high degree of anatomical accuracy. The new Pentaray Nav Catheter is equipped with the electromagnetic sensor, allowing for accurate visualization of electrode position on the Carto 3 system and higher resolution signals.

Multi-electrode mapping represents a significant advancement in mapping technology, allowing physicians to acquire multiple mapping points simultaneously with a high level of detail and Carto 3 system accuracy. Combined with the new Pentaray Nav Catheter, operators can reduce the number of required catheter maneuvers to quickly diagnose any arrhythmia.

For more information: